Longevity, lipotoxicity and leptin: The adipocyte defense against feasting and famine

Biochimie

Volumn 87, Issue 1 SPEC. ISS., 2005, Pages 57-64

  Unger, Roger H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Ceramide; Leptin; Lipodystrophy; Lipotoxicity; Longevity; Metabolic syndrome; Obesity

Indexed keywords

LEPTIN;

ADIPOCYTE; APOPTOSIS; CALORIMETRY; CELL SURVIVAL; CONFERENCE PAPER; CYTOTOXICITY; HUNGER; NONHUMAN; OVERNUTRITION; OXIDATION; PROTEIN FUNCTION;

RODENTIA;

EID: 14544279805     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2004.11.014     Document Type: Conference Paper

References (59)

1. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, and J.G. Wood Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan Nature 425 2003 191 196
2. M.A. Lane, R. de Cabo, J. Mattison, R.M. Anson, G.S. Roth, and D.K. Ingram The Roy Walford legacy: diet restriction from molecules to mice to monkeys to man and onto mimetics Exp. Gerontol. 39 2004 897 902
3. K.J. Bitterman, R.M. Anderson, H.Y. Cohen, M. Latorre-Esteves, and D.A. Sinclair Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1 J. Biol. Chem. 277 2002 45099 45107
4. F. Picard, M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, and R. Machado De Oliveira Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 429 2004 771 776
5. H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, and T.K. Pandita hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
6. M. Shimabukuro, Y.T. Zhou, M. Levi, and R.H. Unger Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes Proc. Natl. Acad. Sci. USA 95 1998 2498 2502
7. M. Shimabukuro, M. Higa, Y.T. Zhou, M.Y. Wang, C.B. Newgard, and R.H. Unger Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression J. Biol. Chem. 273 1998 32487 32490
8. L.L. Listenberger, and J.E. Schaffer Mechanisms of lipoapoptosis: implications for human heart disease Trends Cardiovasc. Med. 12 2002 134 138
9. K. Eitel, H. Staiger, M.D. Brendel, D. Brandhorst, R.G. Bretzel, and H.U. Haring Different role of saturated and unsaturated fatty acids in beta-cell apoptosis Biochem. Biophys. Res. Commun. 299 2002 853 856
10. R.H. Unger Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications Diabetes 44 1995 863 870
11. R.H. Unger, and L. Orci Lipotoxic diseases of nonadipose tissues in obesity Int. J. Obes. Relat. Metab. Disord. 24 Suppl. 4 2000 S28 S32
12. R.H. Unger, and Y.T. Zhou Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover Diabetes 50 Suppl. 1 2001 S118 S121
13. R.H. Unger Lipotoxic diseases Annu. Rev. Med. 53 2002 319 336
14. M. Shimabukuro, K. Koyama, Y. Lee, and R.H. Unger Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity J. Clin. Invest. 100 1997 1750 1754
15. K.A. Hughes, J.A. Alipaz, J.M. Drnevich, and R.M. Reynolds A test of evolutionary theories of aging Proc. Natl. Acad. Sci. USA 99 2002 14286 14291
16. E. Tomas, T.S. Tsao, A.K. Saha, H.E. Murrey, C.C. Zhang, and S.I. Itani Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxyl's inhibition and AMP-activated protein kinase activation Proc. Natl. Acad. Sci. USA 99 2002 16309 16313
17. J.L. Halaas, K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, and D. Rabinowitz Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 1995 543 546
18. M. Shimabukuro, K. Koyama, G. Chen, M.Y. Wang, F. Trieu, and Y. Lee Direct antidiabetic effect of leptin through triglyceride depletion of tissues Proc. Natl. Acad. Sci. USA 94 1997 4637 4641
19. Y. Lee, H. Hirose, Y.T. Zhou, V. Esser, J.D. McGarry, and R.H. Unger Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM Diabetes 46 1997 408 413
20. Y.T. Zhou, M. Shimabukura, Y. Lee, K. Koyama, M. Higa, and T. Ferguson Diabetes 47 1998 1904 1908
21. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
22. Y. Lee, M.Y. Wang, T. Kakuma, Z.W. Wang, E. Babcock, and K. McCorkle Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia J. Biol. Chem. 276 2001 5629 5635
23. R. Unger How adipocytes integrate surplus caloric intake with caloric storage: lessons from Morgan Spurlock and some French geese Curr. Opin. Endocrinol. Diabetes 11 2004 251 257
24. R.H. Unger The physiology of cellular liporegulation Ann. Rev. Physiol. 65 2003 333 337
25. G.M. Reaven Role of insulin resistance in human disease (syndrome X): an expanded definition Annu. Rev. Med. 44 1993 121 131
26. K. Ohashi, N. Ouchi, S. Kihara, T. Funahashi, T. Nakamura, and S. Sumitsuji Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease J. Am. Coll. Cardiol. 43 2004 1195 1200
27. E.A. Sims, and E.S. Horton Endocrine and metabolic adaptation to obesity and starvation Am. J. Clin. Nutr. 21 1968 1455 1470
28. E.A. Sims, E. Danforth Jr., E.S. Horton, G.A. Bray, J.A. Glennon, and L.B. Salans Endocrine and metabolic effects of experimental obesity in man Recent Prog. Horm. Res. 29 1973 457 496
29. E.A. Roberts Nonalcoholic steatohepatitis in children Curr. Gastroenterol. Rep. 5 2003 253 259
30. A.W. Marion, A.J. Baker, and A. Dhawan Fatty liver disease in children Arch. Dis. Child. 89 2004 648 652
31. I. Shimomura, Y. Bashmakov, S. Ikemoto, J.D. Horton, M.S. Brown, and J.L. Goldstein Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes Proc. Natl. Acad. Sci. USA 96 1999 13656 13661
32. H. Yamashita, M. Takenoshita, M. Sakurai, R.K. Bruick, W.J. Henzel, and W. Shillinglaw A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver Proc. Natl. Acad. Sci. USA 98 2001 9116 9121
33. I. Shimomura, R.E. Hammer, S. Ikemoto, M.S. Brown, and J.L. Goldstein Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 1999 73 76
34. E.A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, and P. Snell Leptin-replacement therapy for lipodystrophy N. Engl. J. Med. 346 2003 570 578
35. O. Gavrilova, B. Marcus-Samuels, L.R. Leon, D. Graham, K. Jason, and G.I. Shulman Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice J. Clin. Invest. 105 2000 271 278
36. Z.W. Wang, W.T. Pan, Y. Lee, T. Kakuma, Y.T. Zhou, and R.H. Unger The role of leptin resistance in the lipid abnormalities of aging FASEB J. 15 2000 108 114
37. J.P. Despres The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk Obes. Res. 6 Suppl. 1 1998 8S 17S
38. I. Gabriely, and N. Barzilai Surgical removal of visceral adipose tissue: effects on insulin action Curr. Diab. Rep. 3 2003 201 206
39. G. Atzmon, X.M. Yang, R. Muzumdar, X.H. Ma, I. Gabriely, and N. Barzilai Differential gene expression between visceral and subcutaneous fat depots Horm. Metab. Res. 34 2002 622 628
40. N.B. Ruderman, S.H. Schneider, and P. Berchtold The "metabolically- obese," normal-weight individual Am. J. Clin. Nutr. 34 1981 1617 1621
41. A.G. Rockall, S.A. Sohaib, D. Evans, G. Kaltsas, A.M. Isidori, and J.P. Monson Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography Eur. J. Endocrinol. 149 2003 543 548
42. Y. Lee, H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry, and R.H. Unger Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships Proc. Natl. Acad. Sci. USA 91 1994 10878 10882
43. M. Higa, Y.T. Zhou, M. Ravazzola, D. Baetens, L. Orci, and R.H. Unger Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats Proc. Natl. Acad. Sci. USA 96 1999 11513 11518
44. Y.T. Zhou, P. Grayburn, A. Karim, M. Shimabukuro, M. Higa, and D. Baetens Lipotoxic heart disease in obese rats: implications for human obesity Proc. Natl. Acad. Sci. USA 97 2000 1784 1789
45. S.K. Gan, K. Samaras, C.H. Thompson, E.W. Kraegen, A. Carr, and D.A. Cooper Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy Diabetes 51 2002 3163 3169
46. R. Weiss, S. Dufour, S.E. Taksali, W.V. Tamborlane, K.F. Petersen, and R.C. Bonadonna Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning Lancet 362 2003 951 957
47. L.S. Szczepaniak, R.L. Dobbins, G.J. Metzger, G. Sartoni-D'Ambrosia, D. Arbique, and W. Vongpatanasin Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging Magn. Reson. Med. 49 2003 417 423
48. L.S. Szczepaniak, E.E. Babcock, F. Schick, R.L. Dobbins, A. Garg, and D.K. Burns Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo Am. J. Physiol. 265 1999 E977 E989
49. L.S. Szczepaniak, P. Nurenberg, D. Leonard, J.D. Browning, J.S. Reingold, and S. Grundy Magnetic resonance spectroscopy to measure triglyceride content: Prevalence of hepatic steatosis in the general population Am. J. Physiol. Endocrinol. Metab. 2004 (in press)
50. J. Achten, and A.E. Jeukendrup Optimizing fat oxidation through exercise and diet Nutrition 20 2004 716 727
51. Y. Minokoshi, Y.B. Kim, O.D. Peroni, L.G. Fryer, C. Muller, and D. Carling Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415 2002 339 343
52. A.K. Saha, P.R. Avilucea, J.M. Ye, M.M. Assifi, E.W. Kraegen, and N.B. Ruderman Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo Biochem. Biophys. Res. Commun. 314 2004 580 585
53. L.G. Fryer, A. Parbu-Patel, and D. Carling The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 277 2002 25226 25232
54. M.A. Iglesias, J.M. Ye, G. Frangioudakis, A.K. Saha, E. Tomas, and N.B. Ruderman AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats Diabetes 51 2002 2886 2894
55. B. Weiss, and W. Stoffel Human and murine serine-palmitoyl-CoA transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis Eur. J. Biochem. 249 1997 239 247
56. M. Shimabukura, M. Ohneda, Y. Lee, and R.H. Unger Role of nitric oxide in obesity-induced beta cell disease J. Clin. Invest. 100 1997 290 295
57. H.C. Chiu, A. Kovacs, D.A. Ford, F.F. Hsu, R. Garcia, and P. Herrero A novel mouse model of lipotoxic cardiomyopathy J. Clin. Invest. 107 2001 813 822
58. M. Shimabukura, M.Y. Wang, Y.T. Zhou, C.B. Newgard, and R.H. Unger Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression Proc. Natl. Acad. Sci. USA 95 1998 9558 9561
59. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359